Skip to main content

Armata Pharmaceuticals, Inc.

ARMP
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0000921114

No open-market purchases or sales by Armata Pharmaceuticals, Inc. insiders were filed in the last 90 days; 53 institutions reported holding it in 13F filings for Q2 2026, worth $32.3M in total; no superinvestor holds it.

Members of Congress who traded ARMP

No member of Congress has reported a trade in Armata Pharmaceuticals, Inc. since 2020.

Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.